Clinical Trial Update: Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of sublingual immunotherapy with depigmented-polymerized pollen extracts for allergic rhinoconjunctivitis has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Allergic Rhinitis

Drugs mentioned

• Depigmented-polymerized pollen extract SLIT (depigmented-polymerized pollen extract)

Snippet

Sponsor: Laboratorios Leti, S.L. | Conditions: Allergic Rhinoconjunctivitis | Phase 2 | Status: COMPLETED